Role of Th1 and Th2 cells in neurologic disorders. 1996

A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., USA.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D018417 Th1 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete INTERLEUKIN-2; INTERFERON-GAMMA; and INTERLEUKIN-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions. T Helper 1 Cells,TH-1 Cells,Type 1 Helper T Cells,Cell, TH-1,Cell, Th1,Cells, TH-1,Cells, Th1,TH 1 Cells,TH-1 Cell,Th1 Cell
D018418 Th2 Cells A subset of helper-inducer T-lymphocytes which synthesize and secrete the INTERLEUKINS IL-4; IL-5; IL-6; and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses. T Helper 2 Cell,T Helper2 Cell,TH-2 Cell,Th2 Cell,Type-2 Helper T Cell,T Helper 2 Cells,T Helper2 Cells,TH-2 Cells,Type-2 Helper T Cells,Cell, T Helper2,Cell, TH-2,Cell, Th2,Cells, T Helper2,Cells, TH-2,Cells, Th2,TH 2 Cell,TH 2 Cells,Type 2 Helper T Cell,Type 2 Helper T Cells

Related Publications

A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 1996, Chemical immunology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 1996, Chemical immunology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
November 1999, Inflammatory bowel diseases,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 1998, Research in immunology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 2001, Current opinion in hematology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 1996, Chemical immunology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
December 1996, Trends in microbiology,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
January 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
September 2000, European cytokine network,
A Windhagen, and L B Nicholson, and H L Weiner, and V K Kuchroo, and D A Hafler
September 1996, Harefuah,
Copied contents to your clipboard!